The Philadelphia chromosome (Ph') is of particular interest because of its close association with chronic granulocytic leukaemia. Ph' is a distinct chromosome abnormality which is found in the marrow or blood cells of nearly all patients with this leukaemia, and appears to be generally specific to this or closely related disorders. Because of these features, Ph', unlike the chromosome abnormalities found in other tumours, has a strong claim to a close association with the aetiology of chronic granulocytic leukaemia, but a causal role has not been established. During the chronic phase of this leukaemia, Ph' is the only detectable chromosome change in the majority of cases, whereas in the acute terminal stages, Ph' is commonly associated with other chromosome abnormalities which vary considerably between patients. These secondary abnormalities resemble those found in acute leukaemia which is also characterized by a great variety of chromosome abnormalities, probably as a secondary development of the leukaemic state. Investigations of the transition from specificity to diversity of chromosome abnormality in chronic granulocytic leukaemia are of particular importance, because they might be expected to give some insight, not only into the relationship of chromosome abnormalities to tumour progression, but also into the nature of the specificity of the Ph' chromosome itself.
The present paper reports a complex pattern of chromosome abnormalities in the bone-marrow cells of a 4I-year-old male patient, in the acute phase of the disease, who was a subject of earlier reports (Adams, Fitzgerald, and Gunz, I96I; Fitzgerald, Adams, and Gunz, i963) . Detailed examination of the earlier material and of new material from this man revealed abnormalities of G group chromosomes additional to those reported previously, and also, that the abnormal sizes of the G chromosomes had caused Ph' to be overlooked in cells thought previously to be without it.
Case History
Details of clinical findings and therapeutic measures were presented in an earlier paper (Adams et al., I96I) . The salient features of the now complete case history are as follows: diagnosis of chronic granulocytic leukaemia in the 34-year-old male patient in I954; treatment with splenic X radiation, 32P, and busulphan, which caused an unusually long series of remissions lasting until March i96i when the disease entered an acute phase; treatment with 6-mercaptopurine and prednisone, which resulted in a further remission and return to a practically normal cell composition in marrow and blood; continuation of this remission until the death of the patient in November i96i as a result of a tumour of the pancreas (Angus and Gunz, i963) . Necropsy revealed an adenocarcinoma of high malignancy in the pancreas and widespread secondary growths. The bone-marrow showed tumour deposits as well as groups of blasts.
Chromosome Findings
The chromosomes were examined in marrow cells prepared by a direct method detailed elsewhere (Adams et al., i96i The 2/C translocation was present in some cells of types i and 2, and absent from others, but was never present in cell types 3 and 4 (Table III) . The lack of association in the same cell of the translocation and the minute indicates that they originated independently of each other in different cell lines. The absence of the translocation from both cell types 3 and 4 supports the view that type 4 cells were derived from type 3 cells by loss of the minute chromosome.
The June, July, and October, marrows, all of which were prepared by the direct technique, showed the same four cell types as were present in the March preparation (Table III) (III and IV) carrying the translocation.
Discussion
The marrow cells of this patient showed a complex of abnormalities mainly affecting the G chromosomes but also the A and C groups. All cells showed the Ph' chromosome, which is believed to be concerned closely with the origin of chronic granulocytic leukaemia, and many cells also showed additional G chromosome abnormalities, namely, a second Ph'-like chromosome, a minute chromosome, and complete loss of a G chromosome. These appear to be secondary developments in leukaemic Ph'-positive cells, and were possibly caused by the considerable treatment the patient had received. Ph' has been identified as an autosome, possibly No. 2I, but the identity of the other 3 abnormal G chromosomes is not clear. They may have involved different chromosomes, or they may all have occurred in a particular G chromosome. They probably did not occur in the Y chromosome which appeared to be present in some of the cells with each type of G abnormality, though in other cells this chromosome could not be identified clearly.
Abnormalities similar to the G chromosome abnormalities in this patient have been described in other patients. Nowell and Hungerford (I96I) noted a 46 chromosome cell line with Ph' and a similar abnormally short acrocentric chromosome in a male patient who, like the present one, was in the acute blastic phase after a long history of granulocytic leukaemia, and Forteza and Baguena (I962) described the association in a male patient of Ph' with a minute chromosome replacing another G chromosome. The complete absence of a G chromosome from some marrow cells of the present patient recalls the 45 chromosome cell line, including Ph' and only 3 other small acrocentrics, which has been described in 7 male patients in the chronic phase of granulocytic leukaemia (Atkin and Taylor, I962; Tough, Jacobs, Court Brown, Baikie, and Williamson, I963; Speed and Lawler, I964; Engel, Jenkins, Tipton, McGee, and Engel-de Montmollin, I965; and one unreported case from this laboratory). The G group chromosome abnormalities described in these patients are similar to those found in the present patient, but, like them, their precise identity must remain uncertain because of the obvious difficulty in identifying deleted or missing chromosomes, which is often aggravated by the abnormal appearance of the chromosomes in leukaemic cells (Atkin and Taylor, I962) . However, it may be significant that the io patients in whom these abnormalities occurred, including the present one, were all male. Future findings of these abnormalities in male patients only would strengthen the view that the Y chromosome was involved, whereas their presence in females would indicate that they occurred in an autosome, possibly the homologue of Ph'.
It is possible that the 3 G chromosome abnormalities in the present patient, while being the results of independent events in different cells, exhibit the progressive deletion of a particular G chromosome, and have similar cytogenetic effects, such as might result from the common loss of a particular locus concerned with leucopoiesis. The presence, at the one time, of clones characterized by each of the three chromosome abnormalities suggests that they were genetically similar, though not genetically identical, as is indicated by the changes in frequency of the clones in the four marrow samples. Loss of a particular locus would be achieved most readily by complete loss of a chromosome, and it is possible that the present abnormalities, if they are cytogenetically similar, are basically of the same nature as the more commonly reported absence of a G chromosome in cells carrying Ph' (Atkin and Taylor, I962; Tough et al., I963; Speed and Lawler, I964; Engel et al., I965) .
While the identity and relationships of these abnormal chromosomes are uncertain, complete loss, and possibly partial loss, of a small acrocentric chromosome other than Ph' appears to be a secondary cytogenetic development in several cases of chronic granulocytic leukaemia. This repetition of the same or closely similar abnormalities in different patients recalls the Ph' chromosome itself, and it appears that the factors determining the specific association of Ph' with chronic granulocytic leukaemia, while most strikingly evident with Ph', might also apply to other chromosome abnormalities. 
Summary
Six distinct cell lines, each with the Ph' chromosome, are described with changes in their frequency in four successive bone-marrow samples from a 4I-year-old man in the acute blastic phase of chronic granulocytic leukaemia. Four of the cell lines showed abnormalities of a G group chromosome other than Ph': two showed the development of a second Ph'-like chromosome, one showed deletion of the major part of a G chromosome, and the fourth showed complete loss of one of these chromosomes. It was not clear whether these abnormalities were present in different G chromosomes, or whether they affected the same chromosome. The reported presence in other cases of chronic granulocytic leukaemia of chromosome abnormalities, closely similar to the above, indicates that loss, and possibly partial deletion, of a G group chromosome, apart from Ph', is a secondary cytogenetic change of relatively common occurrence. Thus chronic granulocytic leukaemia is of particular interest not only for its association with the specific abnormality of Ph', but also for its frequent association with other particular chromosome abnormalities.
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